Mitophagy in hepatic ischemia-reperfusion injury

doi:10.16352/j.issn.1001-6325.2024.06.0877

Abstract

Abstract: In case of hepatic ischemia-reperfusion injury (HIRI), mitophagy is induced by multiple pathways such as PINK1/Parkin and mitophagy receptor, which is closely related to mitochondrial dynamic related protein. Mitophagy is a double-edged sword. Moderate mitophagy is effective in reducing the oxidative stress and maintaining mitochondria homeostasis, thereby reducing hepatocyte apoptosis and necrosis, inhibiting inflammation response and mitigating HIRI. However excessive mitophagy will aggravate HIRI. So research on the role and mechanism of mitophagy may facilitate the development of new strategy for prevention and clinical treatment of HIRI.

Key words: hepatic ischemia-reperfusion injury (HIRI), mitophagy, mitochondrial dynamic related protein

CLC Number:

R364

ZHANG Xiangxin, LI Wen. Mitophagy in hepatic ischemia-reperfusion injury[J]. Basic & Clinical Medicine, 2024, 44(6): 877-881.

References 23

[1]	Ning X, Yan X, Wang Y, et al. Parkin deficiency elevates hepatic ischemia/reperfusion injury accompanying decreased mitochondrial autophagy, increased apoptosis, impaired DNA damage repair and altered cell cycle distribution[J]. Mol Med Rep, 2018, 18: 5663-5668.
[2]	Xu M, Hang H, Huang M, et al. DJ-1 deficiency in hepatocytes improves liver ischemia-reperfusion injury by enhancing mitophagy[J]. Cell Mol Gastroenterol Hepatol, 2021, 12: 567-584.
[3]	Cao Q, Luo J, Xiong Y, et al. 25-hydroxycholesterol mitigates hepatic ischemia reperfusion injury via mediating mitophagy[J]. Int Immunopharmacol, 2023, 96: 107643. doi: 10.1016/j.intimp.2021.107643.
[4]	Gu J, Zhang T, Guo J, et al. PINK1 activation and translocation to mitochondria-associated membranes mediates mitophagy and protects against hepatic ischemia/reperfu-sion injury[J]. Shock, 2020, 54: 783-793.
[5]	Wu H, Chen Q. Hypoxia activation of mitophagy and its role in disease pathogenesis[J]. Antioxid Redox Signal, 2015, 22: 1032-1046.
[6]	Zhang W. The mitophagy receptor FUN14 domain-containing 1 (FUNDC1): a promising biomarker and potential therapeutic target of human diseases[J]. Genes Dis, 2021, 8: 640-654.
[7]	Huang J, Xie P, Dong Y, et al. Inhibition of Drp1 SUMOylation by ALR protects the liver from ischemia-reperfusion injury[J]. Cell Death Differ, 2021, 28: 1174-1192.
[8]	Zhou S, Rao Z, Xia Y, et al. CCAAT/enhancer-binding protein homologous protein promotes ROS-mediated liver ischemia and reperfusion injury by inhibiting mitophagy in hepatocytes[J]. Transplantation, 2023, 107: 129-139.
[9]	Basso V, Marchesan E, Peggion C, et al. Regulation of ER-mitochondria contacts by Parkin via Mfn2[J]. Pharmacol Res, 2018, 138: 43-56.
[10]	Chen Y, Dorn GW. PINK1-phosphorylated mitofusin 2 is a Parkin receptor for culling damaged mitochondria[J]. Science, 2013, 340: 471-475.
[11]	Kong W, Li W, Bai C, et al. Augmenter of liver regeneration-mediated mitophagy protects against hepatic ischemia/reperfusion injury[J]. Am J Transplant, 2022, 22: 130-143.
[12]	Kong Z, Zhang Z, Wu B, et al. Increased oxidative stress caused by impaired mitophagy aggravated liver ischemia and reperfusion injury in diabetic mice[J]. J Diabetes Investig, 2023, 14: 28-36.
[13]	Shi Q, Zhao G, Wei S, et al. Pterostilbene alleviates liver ischemia/reperfusion injury via PINK1-mediated mitophagy[J]. J Pharmacol Sci, 2022, 148: 19-30.
[14]	Luo J, Hu Y, Qiao Y, et al. Hypothermic oxygenated machine perfusion promotes mitophagy flux against hypoxia-ischemic injury in rat DCD liver[J]. Int J Mol Sci, 2023, 24: 5403.doi: 10.3390/ijms24065403.
[15]	Zheng J, Chen L, Lu T, et al. MSCs ameliorate hepatocellular apoptosis mediated by PINK1-dependent mito-phagy in liver ischemia/reperfusion injury through AMPKα activation[J]. Cell Death Dis, 2020, 11: 256.doi:10.1038/s41419-020-2424-1.
[16]	Lu Y, Bian J, Kan H, et al. Intermittent hypoxia preconditioning protects WRL68 cells against oxidative injury: Involvement of the PINK1/Parkin-mediated mitophagy regulated by nuclear respiratory factor 1[J]. Mitochondrion, 2021, 59: 113-122.
[17]	录亚鹏, 谢建琴. NLRP3炎性小体在缺血再灌注损伤治疗中作用的研究进展[J]. 基础医学与临床, 2023, 43: 706-710.
[18]	Xu Y, Tang Y, Lu J, et al. PINK1-mediated mitophagy protects against hepatic ischemia/reperfusion injury by restraining NLRP3 inflammasome activation[J]. Free Radic Biol Med, 2023, 160: 871-886.
[19]	Zhang Y, Wang Z, Jia C, et al. Blockade of hepatocyte PCSK9 ameliorates hepatic ischemia-reperfusion injury by promoting PINK1-Parkin-mediated mitophagy[J]. Cell Mol Gastroenterol Hepatol, 2023, 17: 149-169.
[20]	杨超君,王跃武,周开珩. 川陈皮素防治肝缺血再灌注损伤的作用机制研究[J]. 中草药, 2021, 52: 2343-2350.
[21]	Lin J, Qing Z, Huang H, et al. Ginsenoside Rg1 alleviates rat liver ischemia-reperfusion ischemia through mitochondrial autophagy pathway[J]. Alern Ther Health Med, 2023, 29: 16-25.
[22]	Li H, Pan Y, Wu H, et al. Inhibition of excessive mitophagy by N-acetyl-L-tryptophan confers hepatoprotection against ischemia-reperfusion injury in rats[J]. PeerJ, 2020, 8: e8665. doi: 10.7717/peerj.8665.
[23]	Chen K, Li J, Li S, et al. 15-Deoxy-Δ(12,14)-prostaglandin J(2) alleviates hepatic ischemia-reperfusion injury in mice via inducing antioxidant response and inhibiting apoptosis and autophagy[J]. Acta Pharmacol Sin, 2017, 38: 672-687.